These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19571666)

  • 1. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
    Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
    Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC).
    Wlodarczyk B; Gasiorowska A; Malecka-Panas E
    J Clin Gastroenterol; 2018 Aug; 52(7):569-572. PubMed ID: 29912760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
    Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
    Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
    Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
    Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer.
    Satoh M; Takano S; Sogawa K; Noda K; Yoshitomi H; Ishibashi M; Mogushi K; Takizawa H; Otsuka M; Shimizu H; Miyazaki M; Nomura F
    Cancer Sci; 2017 Apr; 108(4):795-803. PubMed ID: 28161904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients With Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus.
    Nagpal SJS; Bamlet WR; Kudva YC; Chari ST
    Pancreas; 2018 Jul; 47(6):738-741. PubMed ID: 29771765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of metabolic pathways could offset the poor prognosis conferred by co-existent diabetes mellitus in pancreatic (head) adenocarcinoma.
    Gardi N; Ketkar M; McKinnon RA; Pandol SJ; Dutt S; Barreto SG
    ANZ J Surg; 2021 Nov; 91(11):2466-2474. PubMed ID: 34514690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H4 expression in normal and diseased human islet β cells.
    Cheung SS; Ou D; Metzger DL; Meloche M; Ao Z; Ng SS; Owen D; Warnock GL
    Pancreas; 2014 Jan; 43(1):128-34. PubMed ID: 24326367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant
    Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
    Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.
    Gao W; Zhou Y; Li Q; Zhou Q; Tan L; Song Y; Zhao X; Yu M; Zheng S; Ye H; Zeng B; Lin Q; Zhou J; Liu Y; Huang H; Zhang H; Hu X; Li Z; Dai X; Chen R
    Diabetologia; 2015 Apr; 58(4):835-44. PubMed ID: 25636208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and tissue metallome of pancreatic ductal adenocarcinoma.
    Byeon S; du Toit-Thompson T; Hipperson L; Maloney S; Wenzel R; Gill AJ; Samra JS; Mittal A; Sahni S
    Cancer Sci; 2024 May; 115(5):1446-1458. PubMed ID: 38438247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma.
    Chen J; Chen LJ; Yang RB; Xia YL; Zhou HC; Wu W; Lu Y; Hu LW; Zhao Y
    Med Oncol; 2013; 30(2):583. PubMed ID: 23609192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.